- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
- Interventions
- Tamsulosin, Placebo
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 55 Years to 80 Years · Male only
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- San Francisco, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 60
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Urological Manifestations
- Interventions
- tamsulosin hydrochloride
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 1,117 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 40
- States / cities
- Birmingham, Alabama • Homewood, Alabama • Hoover, Alabama + 35 more
- Conditions
- Post Operative Urinary Retention
- Interventions
- Tamsulosin, Placebo
- Drug
- Lead sponsor
- Jewish Hospital, Cincinnati, Ohio
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 170 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Prostatic Hyperplasia
- Interventions
- Treatment sequence A, Treatment sequence B, Treatment sequence C, Treatment sequence D
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 45 Years · Male only
- Enrollment
- 81 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2008
- U.S. locations
- 2
- States / cities
- Evansville, Indiana • Austin, Texas
- Conditions
- Postoperative Urinary Tract Infection
- Interventions
- Tamsulosin, Control Group
- Drug · Other
- Lead sponsor
- Emory University
- Other
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 4
- States / cities
- Atlanta, Georgia • Johns Creek, Georgia
- Conditions
- Urinary Retention
- Interventions
- Tamsulosin 0.4Mg Capsule, Placebo oral tablet
- Drug
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- Weston, Florida
- Conditions
- Post-Operative Urinary Retention
- Interventions
- Tamsulosin, Education
- Drug · Other
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Overactive Bladder, Lower Urinary Tract Symptoms
- Interventions
- Behavioral training, Tolterodine + tamsulosin, Combined Behavioral + Drug Therapy
- Behavioral · Drug · Other
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 204 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Atlanta, Georgia • San Antonio, Texas
- Conditions
- Urolithiasis
- Interventions
- Flomax, Sugar pill
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Ureteral Diseases
- Interventions
- Tamsulosin BID, Placebo
- Drug · Other
- Lead sponsor
- Gundersen Lutheran Medical Foundation
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- La Crosse, Wisconsin
- Conditions
- Prostate Cancer
- Interventions
- tamsulosin and/or dutasteride
- Drug
- Lead sponsor
- Case Comprehensive Cancer Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 348 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Kidney Stones, Ureteral Stones
- Interventions
- Tamsulosin, Placebo
- Drug
- Lead sponsor
- Robert Swor
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 127 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2011
- U.S. locations
- 1
- States / cities
- Royal Oak, Michigan
- Conditions
- Postoperative Urinary Retention
- Interventions
- Tamsulosin, Placebo
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 35 Years and older · Male only
- Enrollment
- 176 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Erectile Dysfunction
- Interventions
- Tamsulosin and avanafil, Doxazosin and avanafil
- Drug
- Lead sponsor
- VIVUS LLC
- Industry
- Eligibility
- 40 Years to 65 Years · Male only
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Tempe, Arizona
- Conditions
- Prostatic Hyperplasia
- Interventions
- GI198745
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 45 Years · Male only
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Buffalo, New York
- Conditions
- Urinary Retention
- Interventions
- Tamsulosin
- Drug
- Lead sponsor
- Hackensack Meridian Health
- Other
- Eligibility
- 55 Years and older · Male only
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 4
- States / cities
- Brick, New Jersey • Manahawkin, New Jersey • Neptune City, New Jersey + 1 more
- Conditions
- Nocturia
- Interventions
- Behavioral, tamsulosin (alpha-adrenergic antagonist medication), placebo, placebo
- Behavioral · Drug
- Lead sponsor
- Atlanta VA Medical Center
- Federal
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 72 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2014
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Atlanta, Georgia
- Conditions
- Urinary Retention Postoperative
- Interventions
- Tamsulosin, Placebo
- Drug
- Lead sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 154 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2026
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Bladder, Neurogenic
- Interventions
- tamsulosin hydrochloride, Placebo
- Drug
- Lead sponsor
- Boehringer Ingelheim
- Industry
- Eligibility
- 2 Years to 16 Years
- Enrollment
- 231 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Tampa, Florida • St Louis, Missouri + 4 more
- Conditions
- Postoperative Urinary Retention
- Interventions
- Tamsulosin hydrochloride, Placebo
- Drug · Other
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 35 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Nephrolithiasis, Ureteral Calculi
- Interventions
- tamsulosin, Standard therapy with ibuprofen and oxycodone.
- Drug
- Lead sponsor
- MaineHealth
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Portland, Maine
- Conditions
- Prostate Cancer Patients Undergoing External Radiation and Seed Implantation
- Interventions
- Not listed
- Lead sponsor
- Dattoli Cancer Center and Brachytherapy Research Institute
- Other
- Eligibility
- 45 Years to 80 Years · Male only
- Enrollment
- 60 participants
- Timeline
- 2005
- U.S. locations
- 1
- States / cities
- Sarasota, Florida
- Conditions
- Urethral Sphincter Activity
- Interventions
- Pseudoephedrine, Tamsulosin, Imipramine, Cyclobenzaprine, Lactose capsule, Solifenacin
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 19 Years to 51 Years · Female only
- Enrollment
- 56 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Hernia, Urinary Retention
- Interventions
- Tamsulosin
- Drug
- Lead sponsor
- Memorial Health University Medical Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Savannah, Georgia